Efthymios N. Deliargyris
2023
In 2023, Efthymios N. Deliargyris earned a total compensation of $1.1M as Chief Medical Officer at Cytosorbents, a 5% increase compared to previous year.
Compensation breakdown
| Bonus | $164,778 |
|---|---|
| Option Awards | $276,204 |
| Salary | $408,100 |
| Stock Awards | $194,150 |
| Other | $12,500 |
| Total | $1,055,732 |
Deliargyris received $408.1K in salary, accounting for 39% of the total pay in 2023.
Deliargyris also received $164.8K in bonus, $276.2K in option awards, $194.2K in stock awards and $12.5K in other compensation.
Rankings
In 2023, Efthymios N. Deliargyris' compensation ranked 1,149th out of 3,006 executives tracked by ExecPay. In other words, Deliargyris earned more than 61.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,149 out of 3,006 | 62nd |
Division Manufacturing | 688 out of 1,650 | 58th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 87 out of 256 | 66th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 59 out of 188 | 69th |
Industry Surgical and Medical Instruments and Apparatus | 53 out of 144 | 63rd |
Source: SEC filing on April 19, 2024.
Deliargyris' colleagues
We found three more compensation records of executives who worked with Efthymios N. Deliargyris at Cytosorbents in 2023.